...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.
【24h】

Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.

机译:耐药性选择研究比较了razupenem(PTZ601)对万古霉素和利奈唑胺对八种耐甲氧西林和两种对甲氧西林敏感的金黄色葡萄球菌菌株的活性。

获取原文
获取原文并翻译 | 示例

摘要

Multistep and single-step resistance selection studies were performed with razupenem, linezolid, and vancomycin against 10 methicillin (meticillin)-resistant and -susceptible Staphylococcus aureus strains. After 20 daily subcultures, razupenem yielded only clones with MICs of >4 microg/ml in one strain (8 microg/ml) whose parent's MIC was already 4 microg/ml. After 18 to 49 passages in 6/10 strains, razupenem MICs rose from 0.016 to 2 microg/ml (parents) to 0.125 to 8 microg/ml (with clones stable after 10 drug-free subcultures). Single-step mutant selection frequencies were similarly low for razupenem and comparators.
机译:用瑞沙培南,利奈唑胺和万古霉素针对10种耐甲氧西林(美西林)和敏感的金黄色葡萄球菌菌株进行了多步和单步耐药选择研究。在每天进行20次传代培养后,razupenem仅在一个亲本MIC已为4 microg / ml的菌株(8 microg / ml)中产生MIC> 4 microg / ml的克隆。在6/10个菌株中传代18到49次后,razupenem MICs从0.016到2 microg / ml(父母)上升到0.125到8 microg / ml(克隆在经过10次无药物继代培养后保持稳定)。 razupenem和比较剂的单步突变选择频率同样较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号